KELLY SMITH-RIGGLEMAN: Open Payments
NPI 1033184981 · PETERSBURG, WV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$829 in 32 payments from 16 companies in 2025. Trend: 2023 $858 · 2024 $1,126 · 2025 $829
Food & beverage: $638Education: $191
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 2 | $110 |
| Novartis Pharmaceuticals Corporation | 5 | $107 |
| SOBI, INC | 1 | $100 |
| ABBVIE INC. | 4 | $100 |
| Janssen Biotech, Inc. | 4 | $70 |
| Eisai Inc. | 3 | $60 |
| GlaxoSmithKline, LLC. | 2 | $51 |
| Merck Sharp & Dohme LLC | 2 | $44 |
| AstraZeneca Pharmaceuticals LP | 2 | $39 |
| Genentech USA, Inc. | 1 | $27 |
Products named: EPKINLY, PLUVICTO, Venclexta, ZEJULA, KEYTRUDA, Lenvima, TECVAYLI, KISQALI.
Industry payments across WV — which companies pay providers there.
